BNXTF
Price
$0.50
Change
-$0.03 (-5.66%)
Updated
Nov 18 closing price
Capitalization
57.17M
Intraday BUY SELL Signals
CNADF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Apr 10 closing price
Capitalization
3.94M
Intraday BUY SELL Signals
Interact to see
Advertisement

BNXTF vs CNADF

Header iconBNXTF vs CNADF Comparison
Open Charts BNXTF vs CNADFBanner chart's image
BIONXT SOLUTIONS
Price$0.50
Change-$0.03 (-5.66%)
Volume$270
Capitalization57.17M
CANADABIS CAP
Price$0.06
Change-$0.00 (-0.00%)
Volume$6K
Capitalization3.94M
BNXTF vs CNADF Comparison Chart in %
BNXTF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BNXTF vs. CNADF commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNXTF is a Hold and CNADF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (BNXTF: $0.50 vs. CNADF: $0.06)
Brand notoriety: BNXTF and CNADF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BNXTF: 2% vs. CNADF: 100%
Market capitalization -- BNXTF: $57.17M vs. CNADF: $3.95M
BNXTF [@Pharmaceuticals: Generic] is valued at $57.17M. CNADF’s [@Pharmaceuticals: Generic] market capitalization is $3.95M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNXTF’s FA Score shows that 0 FA rating(s) are green whileCNADF’s FA Score has 1 green FA rating(s).

  • BNXTF’s FA Score: 0 green, 5 red.
  • CNADF’s FA Score: 1 green, 4 red.
According to our system of comparison, CNADF is a better buy in the long-term than BNXTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNXTF’s TA Score shows that 5 TA indicator(s) are bullish.

  • BNXTF’s TA Score: 5 bullish, 4 bearish.

Price Growth

BNXTF (@Pharmaceuticals: Generic) experienced а -9.44% price change this week, while CNADF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.77%. For the same industry, the average monthly price growth was -6.55%, and the average quarterly price growth was +28.28%.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.77% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNXTF($57.2M) has a higher market cap than CNADF($3.94M). BNXTF YTD gains are higher at: 97.052 vs. CNADF (78.571). CNADF has higher annual earnings (EBITDA): 1.54M vs. BNXTF (-4.93M). CNADF has more cash in the bank: 948K vs. BNXTF (4.24K). BNXTF has less debt than CNADF: BNXTF (7.06M) vs CNADF (9.18M). CNADF has higher revenues than BNXTF: CNADF (17.2M) vs BNXTF (21.7K).
BNXTFCNADFBNXTF / CNADF
Capitalization57.2M3.94M1,453%
EBITDA-4.93M1.54M-319%
Gain YTD97.05278.571124%
P/E RatioN/A11.57-
Revenue21.7K17.2M0%
Total Cash4.24K948K0%
Total Debt7.06M9.18M77%
FUNDAMENTALS RATINGS
BNXTF: Fundamental Ratings
BNXTF
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNXTFCNADF
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
26%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
27%
Advances
ODDS (%)
Bullish Trend 6 days ago
71%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BNXTF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBBMF0.13N/A
N/A
LUX METALS CORP
CIWV34.00N/A
N/A
Citizens Financial Corp. (WV)
PIAGF2.10N/A
N/A
Piaggio & C Spa Pontedera
NNCHF32.00N/A
N/A
Nissan Chemical Corporation
PDRDF92.70-1.13
-1.20%
Pernod Ricard S.A.

CNADF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNADF has been loosely correlated with BJTRF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CNADF jumps, then BJTRF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNADF
1D Price
Change %
CNADF100%
N/A
BJTRF - CNADF
61%
Loosely correlated
N/A
PLSH - CNADF
21%
Poorly correlated
N/A
HLN - CNADF
15%
Poorly correlated
-0.72%
PLNH - CNADF
5%
Poorly correlated
-3.54%
BNXTF - CNADF
4%
Poorly correlated
-5.79%
More